Cited by 3,153CRISPR and Genetic EngineeringRNA regulation and diseaseRNA Interference and Gene Delivery

The DOI matches its Crossref record; 101 of the 102 references it cites were found in a registry or an index.

CRISPR-Cas systems for editing, regulating and targeting genomes

Open access

Sander, Jeffry D, Joung, J Keith·2014·Nature Biotechnology

Open this paper in CoChat — free account

Abstract

Targeted genome editing using engineered nucleases has rapidly gone from being a niche technology to a mainstream method used by many biological researchers. This widespread adoption has been largely fueled by the emergence of the clustered, regularly interspaced, short palindromic repeat (CRISPR) technology, an important new approach for generating RNA-guided nucleases, such as Cas9, with customizable specificities. Genome editing mediated by these nucleases has been used to rapidly, easily and efficiently modify endogenous genes in a wide variety of biomedically important cell types and in organisms that have traditionally been challenging to manipulate genetically. Furthermore, a modified version of the CRISPR-Cas9 system has been developed to recruit heterologous domains that can regulate endogenous gene expression or label specific genomic loci in living cells. Although the genome-wide specificities of CRISPR-Cas9 systems remain to be fully defined, the power of these systems to perform targeted, highly efficient alterations of genome sequence and gene expression will undoubtedly transform biological research and spur the development of novel molecular therapeutics for human disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nbt.2842

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696
One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495

Flagged first, then by citations

Show all 102 references

1 of the 102 references couldn’t be matched to a known paper.

Sorted by citations

Items 701–800 of 1,015

CRISPR/Cas9 produces anti-hepatitis B virus effect in hepatoma cells and transgenic mouse
Zhu, W., Xie, K., Xu, Y., Wang, L., Chen, K., Zhang, L., & Fang, J. (2016) · Virus Research · doi:10.1016/j.virusres.2016.04.003 · Cited by 66
Proteomics to study DNA-bound and chromatin-associated gene regulatory complexes
Wierer, M., & Mann, M. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw208 · Cited by 71
Organoid technologies meet genome engineering
Nie, J., & Hashino, E. (2017) · EMBO Reports · doi:10.15252/embr.201643732 · Cited by 69
Tiny RNAs and their voyage via extracellular vesicles: Secretion of bacterial small RNA and eukaryotic microRNA
Choi, J.-W., Um, J., Cho, J.-H., & Lee, H. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217723166 · Cited by 67
Targeted Approaches for In Situ Gut Microbiome Manipulation
Lee, H. L., Shen, H., Hwang, I. Y., Ling, H., Yew, W. S., Lee, Y. S., & Chang, M. W. (2018) · Genes · doi:10.3390/genes9070351 · Cited by 68
Biosensor libraries harness large classes of binding domains for construction of allosteric transcriptional regulators
Juárez, J. F., Lecube-Azpeitia, B., Brown, S. L., Johnston, C. D., & Church, G. M. (2018) · Nature Communications · doi:10.1038/s41467-018-05525-6 · Cited by 71
Lineage tracing using a Cas9-deaminase barcoding system targeting endogenous L1 elements
Hwang, B., Lee, W., Yum, S.-Y., Jeon, Y., Cho, N., Jang, G., & Bang, D. (2019) · Nature Communications · doi:10.1038/s41467-019-09203-z · Cited by 65
Gene and cell‐based therapies for inherited retinal disorders: An update
Sengillo, J. D., Justus, S., Tsai, Y., Cabral, T., & Tsang, S. H. (2016) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31534 · Cited by 70
Strategies for precision modulation of gene expression by epigenome editing: an overview
Laufer, B. I., & Singh, S. M. (2015) · Epigenetics & Chromatin · doi:10.1186/s13072-015-0023-7 · Cited by 70
A versatile reporter system for CRISPR-mediated chromosomal rearrangements
Li, Y., Park, A. I., Mou, H., Colpan, C., Bizhanova, A., Akama‐Garren, E. H., Joshi, N., Hendrickson, E. A., Feldser, D. M., Yin, H., et al. (2015) · Genome biology · doi:10.1186/s13059-015-0680-7 · Cited by 64
The Development of a Viral Mediated CRISPR/Cas9 System with Doxycycline Dependent gRNA Expression for Inducible In vitro and In vivo Genome Editing
de Solis, C. A., Ho, A., Holehonnur, R., & Ploski, J. E. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00070 · Cited by 65
Genome editing in Shiraia bambusicola using CRISPR-Cas9 system
Deng, H., Gao, R., Liao, X., & Cai, Y. (2017) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2017.06.1204 · Cited by 65
Cell Line Techniques and Gene Editing Tools for Antibody Production: A Review
Dangi, A. K., Sinha, R., Dwivedi, S., Gupta, S. K., & Shukla, P. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00630 · Cited by 66
The Coming Age of Insect Cells for Manufacturing and Development of Protein Therapeutics
Yee, C. M., Zak, A. J., Hill, B., & Wen, F. (2018) · Industrial & Engineering Chemistry Research · doi:10.1021/acs.iecr.8b00985 · Cited by 65
Generation and characterization of a novel knockin minipig model of Hutchinson-Gilford progeria syndrome
Dorado, B., Pløen, G. G., Barettino, A., Macías, Á., Gonzalo, P., Andrés‐Manzano, M. J., González‐Gómez, C., Galán‐Arriola, C., Alfonso, J. M., Lobo, M., et al. (2019) · Cell Discovery · doi:10.1038/s41421-019-0084-z · Cited by 68
Unified energetics analysis unravels SpCas9 cleavage activity for optimal gRNA design
Zhang, D., Hurst, T., Duan, D., & Chen, S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820523116 · Cited by 63
CRISPR/Cas9-mediated gene deletion of the ompA gene in symbiotic Cedecea neteri impairs biofilm formation and reduces gut colonization of Aedes aegypti mosquitoes
Hegde, S. M., Nilyanimit, P., Kozlova, E., Anderson, E. R., Narra, H. P., Sahni, S., Heinz, E., & Hughes, G. L. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007883 · Cited by 64
Perturbing proteomes at single residue resolution using base editing
Després, P. C., Dubé, A. K., Seki, M., Yachie, N., & Landry, C. R. (2020) · Nature Communications · doi:10.1038/s41467-020-15796-7 · Cited by 65
CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease
Rahman, M. U., Bilal, M., Shah, J. A., Kaushik, A. K., Teissèdre, P., & Kujawska, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061252 · Cited by 65
Diatom pyrenoids are encased in a protein shell that enables efficient CO2 fixation
Shimakawa, G., Demulder, M., Flori, S., Kawamoto, A., Tsuji, Y., Nawaly, H., Tanaka, A., Tohda, R., Ota, T., Matsui, H., et al. (2024) · Cell · doi:10.1016/j.cell.2024.09.013 · Cited by 68
Identification of loci that cause phenotypic variation in diverse species with the reciprocal hemizygosity test
Stern, D. L. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.09.006 · Cited by 65
Application of CRISPR/Cas9 genome editing to the study and treatment of disease
Pellagatti, A., Dolatshad, H., Valletta, S., & Boultwood, J. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1504-y · Cited by 65
Somatic cell nuclear transfer: origins, the present position and future opportunities
Wilmut, I., Bai, Y., & Taylor, J. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0366 · Cited by 64
Towards development of new ornamental plants: status and progress in wide hybridization
Kuligowska, K., Lütken, H., & Müller, R. (2016) · Planta · doi:10.1007/s00425-016-2493-7 · Cited by 65
Structural and molecular bases of rod photoreceptor morphogenesis and disease
Wensel, T. G., Zhang, Z., Anastassov, I., Gilliam, J. C., He, F., Schmid, M. F., & Robichaux, M. A. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.06.002 · Cited by 63
A Survey of Computational Methods for Protein Function Prediction
Shehu, A., Barbará, D., & Molloy, K. (2016) · Springer eBooks · doi:10.1007/978-3-319-41279-5_7 · Cited by 65
Advances in detecting and reducing off-target effects generated by CRISPR-mediated genome editing
Li, J., Hong, S., Chen, W., Zuo, E., & Yang, H. (2019) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2019.11.002 · Cited by 66
Versatile single-step-assembly CRISPR/Cas9 vectors for dual gRNA expression
Adikusuma, F., Pfitzner, C., & Thomas, P. Q. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187236 · Cited by 58
Tailored Pig Models for Preclinical Efficacy and Safety Testing of Targeted Therapies
Klymiuk, N., Seeliger, F., Bohlooly‐Y, M., Blutke, A., Rudmann, D. G., & Wolf, E. (2015) · Toxicologic Pathology · doi:10.1177/0192623315609688 · Cited by 66
Fully Automated One-Step Synthesis of Single-Transcript TALEN Pairs Using a Biological Foundry
Chao, R., Liang, J., Tasan, I., Si, T., Ju, L., & Zhao, H. (2017) · ACS Synthetic Biology · doi:10.1021/acssynbio.6b00293 · Cited by 63
Genome editing technologies and their applications in crop improvement
Mishra, R., & Zhao, K. (2018) · Plant Biotechnology Reports · doi:10.1007/s11816-018-0472-0 · Cited by 72
Breeding, Genetics, and Genomics Approaches for Improving Fusarium Wilt Resistance in Major Grain Legumes
Jha, U. C., Bohra, A., Pandey, S., & Parida, S. K. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.01001 · Cited by 62
CRISPR/Cas9-Based Genome Editing and Its Application in Aspergillus Species
Jin, F., Wang, B., Wang, Z., Jin, L., & Han, P. D. (2022) · Journal of Fungi · doi:10.3390/jof8050467 · Cited by 67
Bacterial genome engineering using CRISPR-associated transposases
Gelsinger, D. R., Vo, P. L. H., Klompe, S. E., Ronda, C., Wang, H. H., & Sternberg, S. H. (2024) · Nature Protocols · doi:10.1038/s41596-023-00927-3 · Cited by 62
Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer
Falahi, F., van Kruchten, M., Martinet, N., Hospers, G. A. P., & Rots, M. G. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0412-z · Cited by 62
An Overview of CRISPR-Based Tools and Their Improvements: New Opportunities in Understanding Plant–Pathogen Interactions for Better Crop Protection
Barakate, A., & Stephens, J. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.00765 · Cited by 64
The Search for Resistance to Cassava Mosaic Geminiviruses: How Much We Have Accomplished, and What Lies Ahead
Fondong, V. N. (2017) · Frontiers in Plant Science · doi:10.3389/fpls.2017.00408 · Cited by 62
Liver diseases in the dish: iPSC and organoids as a new approach to modeling liver diseases
Fiorotto, R., Amenduni, M., Mariotti, V., Fabris, L., Spirlı̀, C., & Strazzabosco, M. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.08.038 · Cited by 63
Delivering on the promise of gene editing for cystic fibrosis
Hodges, C. A., & Conlon, R. A. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.11.005 · Cited by 63
Efficient generation of Knock-in/Knock-out marmoset embryo via CRISPR/Cas9 gene editing
Kumita, W., Sato, K., Suzuki, Y., Kurotaki, Y., Harada, T., Zhou, Y., Kishi, N., Sato, K., Aiba, A., Sakakibara, Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49110-3 · Cited by 64
Customizing the genome as therapy for the β-hemoglobinopathies.
Canver, M. C., & Orkin, S. H. (2016) · Blood · doi:10.1182/blood-2016-01-678128 · Cited by 61
Multiplexed Knockouts in the Model Diatom Phaeodactylum by Episomal Delivery of a Selectable Cas9
Moosburner, M., Gholami, P., McCarthy, J. K., Tan, M. H., Bielinski, V. A., & Allen, A. E. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00005 · Cited by 61
CRISPR /Cas‐based tools for the targeted control of plant viruses
Robertson, G., Burger, J. T., & Campa, M. (2022) · Molecular Plant Pathology · doi:10.1111/mpp.13252 · Cited by 62
Using CRISPR-Cas9 to quantify the contributions of O-glycans, N-glycans and Glycosphingolipids to human leukocyte-endothelium adhesion
Stolfa, G., Mondal, N., Zhu, Y., Yu, X., Buffone, A., & Neelamegham, S. (2016) · Scientific Reports · doi:10.1038/srep30392 · Cited by 61
CRISPR-Cas Technologies and Applications in Food Bacteria
Stout, E., Klaenhammer, T. R., & Barrangou, R. (2017) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-072816-024723 · Cited by 65
Genetic and pharmacological inhibition of CDK9 drives neutrophil apoptosis to resolve inflammation in zebrafish in vivo
Hoodless, L. J., Lucas, C. D., Duffin, R., Denvir, M. A., Haslett, C., Tucker, C. S., & Rossi, A. G. (2016) · Scientific Reports · doi:10.1038/srep36980 · Cited by 61
Efficient and modular CRISPR‐Cas9 vector system for Physcomitrella patens
Mallett, D. R., Chang, M., Cheng, X., & Bezanilla, M. (2019) · Plant Direct · doi:10.1002/pld3.168 · Cited by 55
MLL leukemia induction by genome editing of human CD34+ hematopoietic cells
Buechele, C., Breese, E. H., Schneidawind, D., Lin, C.-H., Jeong, J., Duque-Afonso, J., Wong, S. H. K., Smith, K. S., Negrin, R. S., Porteus, M., et al. (2015) · Blood · doi:10.1182/blood-2015-05-646398 · Cited by 60
The Horizon of Gene Therapy in Modern Medicine: Advances and Challenges
Arjmand, B., Larijani, B. A., Hosseini, M. S., Payab, M., Gilany, K., Goodarzi, P., Roudsari, P. P., Amanollahi, M., & Mohammadi, N. S. H. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2019_463 · Cited by 63
Adenoviral vectors for in vivo delivery of CRISPR-Cas gene editors
Rice-Boucher, P. J., Cui, X., & Curiel, D. T. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.003 · Cited by 62
Expanding the Knowledge on the Skillful Yeast Cyberlindnera jadinii
Sousa-Silva, M., Vieira, D., Soares, P. A., Casal, M., & Soares‐Silva, I. (2021) · Journal of Fungi · doi:10.3390/jof7010036 · Cited by 60
Cas-Database: web-based genome-wide guide RNA library design for gene knockout screens using CRISPR-Cas9
Park, J., Kim, J., & Bae, S. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw103 · Cited by 59
Expansion of CRISPR targeting sites in Bombyx mori
Zeng, B., Zhan, S., Wang, Y., Huang, Y., Xu, J. Q., Liu, Q., Li, Z., Huang, Y., & Tan, A. (2016) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2016.03.006 · Cited by 60
Evolutionary tuning of TRPA1 and TRPV1 thermal and chemical sensitivity in vertebrates
Saito, S., & Tominaga, M. (2017) · Temperature · doi:10.1080/23328940.2017.1315478 · Cited by 67
Integrated “omics” approaches to sustain global productivity of major grain legumes under heat stress
Jha, U. C., Bohra, A., Parida, S. K., & Jha, R. (2017) · Plant Breeding · doi:10.1111/pbr.12489 · Cited by 61
Building a Safer and Faster CAR: Seatbelts, Airbags, and CRISPR
Perales, M.-A., Kebriaei, P., Kean, L. S., & Sadelain, M. (2018) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2017.10.017 · Cited by 59
Post-translational modification: a strategic response to high temperature in plants
Han, D., Yu, Z., Lai, J., & Yang, C. (2022) · aBIOTECH · doi:10.1007/s42994-021-00067-w · Cited by 62
Current trends of clinical trials involving CRISPR/Cas systems
Zhang, S., Wang, Y., Mao, D., Wang, Y., Zhang, H., Pan, Y., Wang, Y., Teng, S., & Huang, P. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1292452 · Cited by 62
Effects of hypoxia-induced neonatal seizures on acute hippocampal injury and later-life seizure susceptibility and anxiety-related behavior in mice
Rodriguez-Alvarez, N., Jimenez-Mateos, E. M., Dunleavy, M., Waddington, J. L., Boylan, G. B., & Henshall, D. C. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.023 · Cited by 59
Precision genome editing: A small revolution for glycobiology
Steentoft, C., Bennett, E., Schjoldager, K. T.-B. G., Vakhrushev, S. Y., Wandall, H. H., & Clausen, H. (2014) · Glycobiology · doi:10.1093/glycob/cwu046 · Cited by 62
Review: Neuropathology and behavioural features of transgenic murine models of Alzheimer's disease
Ameen‐Ali, K. E., Wharton, S. B., Simpson, J. E., Heath, P. R., Sharp, P. S., & Berwick, J. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12440 · Cited by 59
An efficient and scalable pipeline for epitope tagging in mammalian stem cells using Cas9 ribonucleoprotein
Dewari, P. S., Southgate, B., McCarten, K., Monogarov, G., O’Duibhir, E., Quinn, N., Tyrer, A., Leitner, M.-C., Plumb, C., Kalantzaki, M., et al. (2018) · eLife · doi:10.7554/elife.35069 · Cited by 63
Genome editing reagent delivery in plants
Ghogare, R., Ludwig, Y., Bueno, G. M., Slamet-Loedin, I. H., & Dhingra, A. (2021) · Transgenic Research · doi:10.1007/s11248-021-00239-w · Cited by 61
Conformational Dynamics and Cleavage Sites of Cas12a Are Modulated by Complementarity between crRNA and DNA
Zhang, L., Sun, R., Yang, M., Peng, S., Cheng, Y., & Chen, C. (2019) · iScience · doi:10.1016/j.isci.2019.08.005 · Cited by 58
CRISPR‐Cas12a System for Biosensing and Gene Regulation
Shi, Y., Fu, X., Yin, Y., Peng, F., Yin, X., Ke, G., & Zhang, X. (2021) · Chemistry - An Asian Journal · doi:10.1002/asia.202100043 · Cited by 58
Impact of CRISPR-Cas9-Based Genome Engineering in Farm Animals
Singh, P., & Ali, S. A. (2021) · Veterinary Sciences · doi:10.3390/vetsci8070122 · Cited by 64
EGFR‐Induced and c‐Src‐Mediated CD47 Phosphorylation Inhibits TRIM21‐Dependent Polyubiquitylation and Degradation of CD47 to Promote Tumor Immune Evasion
Du, L., Su, Z., Wang, S., Meng, Y., Xiao, F., Xu, D., Li, X., Qian, X., Lee, S. B., Lee, J., et al. (2023) · Advanced Science · doi:10.1002/advs.202206380 · Cited by 61
An Open-Source System for In Planta Gene Stacking by Bxb1 and Cre Recombinases
Hou, L., Yau, Y., Wei, J., Han, Z., Dong, Z., & Ow, D. W. (2014) · Molecular Plant · doi:10.1093/mp/ssu107 · Cited by 58
Connecting genotypes, phenotypes and fitness: harnessing the power of CRISPR /Cas9 genome editing
Bono, J. M., Olesnicky, E. C., & Matzkin, L. M. (2015) · Molecular Ecology · doi:10.1111/mec.13252 · Cited by 61
Advances in genome editing technology and its promising application in evolutionary and ecological studies
Chen, L., Tang, L., Xiang, H., Jin, L., Li, Q., Dong, Y., Wang, W., & Zhang, G. (2014) · GigaScience · doi:10.1186/2047-217x-3-24 · Cited by 62
FGFR3-TACC3 fusion proteins act as naturally occurring drivers of tumor resistance by functionally substituting for EGFR/ERK signaling
Daly, C., Castanaro, C., Zhang, W., Zhang, Q., Wei, Y., Ni, M., Young, T. M., Zhang, L., Burova, E., & Thurston, G. (2016) · Oncogene · doi:10.1038/onc.2016.216 · Cited by 58
A dynamic pathway analysis approach reveals a limiting futile cycle in N-acetylglucosamine overproducing Bacillus subtilis
Liu, Y., Link, H., Liu, L., Du, G., Chen, J., & Sauer, U. (2016) · Nature Communications · doi:10.1038/ncomms11933 · Cited by 58
Advancing epilepsy treatment through personalized genetic zebrafish models
Griffin, A., Krasniak, C. S., & Baraban, S. C. (2016) · Progress in brain research · doi:10.1016/bs.pbr.2016.03.012 · Cited by 60
Sendai virus, an RNA virus with no risk of genomic integration, delivers CRISPR/Cas9 for efficient gene editing
Park, A., Hong, P. W.-P., Won, S. T., Thibault, P. A., Vigant, F., Oguntuyo, K. Y., Taft, J. D., & Lee, B. (2016) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2016.57 · Cited by 60
Tools and applications in synthetic biology
MacDonald, I. C., & Deans, T. L. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.08.008 · Cited by 63
Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection
Zou, Z., Huang, K. L., Wei, Y., Chen, H., Liu, Z., & Jin, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-01554-1 · Cited by 58
Preclinical imaging methods for assessing the safety and efficacy of regenerative medicine therapies
Scarfe, L., Brillant, N., Kumar, J. D., Ali, N., Alrumayh, A., Amali, M. O., Barbellion, S., Jones, V., Niemeijer, M., Potdevin, S., et al. (2017) · npj Regenerative Medicine · doi:10.1038/s41536-017-0029-9 · Cited by 57
The Impact of CRISPR/Cas9 Technology on Cardiac Research: From Disease Modelling to Therapeutic Approaches
Motta, B. M., Pramstaller, P. P., Hicks, A. A., & Rossini, A. (2017) · Stem Cells International · doi:10.1155/2017/8960236 · Cited by 64
Identifying and detecting potentially adverse ecological outcomes associated with the release of gene-drive modified organisms
Hayes, K. R., Hosack, G. R., Dana, G. V., Foster, S. D., Ford, J. H., Thresher, R., Ickowicz, A., Peel, D. A., Tizard, M. L., Barro, P. D., et al. (2018) · Journal of Responsible Innovation · doi:10.1080/23299460.2017.1415585 · Cited by 59
Concepts in Light Microscopy of Viruses
Witte, R., Andriasyan, V., Georgi, F., Yakimovich, A., & Greber, U. F. (2018) · Viruses · doi:10.3390/v10040202 · Cited by 59
Targeted Therapies in Genetic Dilated and Hypertrophic Cardiomyopathies: From Molecular Mechanisms to Therapeutic Targets. A Position Paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)
de Boer, R. A., Heymans, S. R. B., Backs, J., Carrier, L., Coats, A. J. S., Dimmeler, S., Eschenhagen, T., Filippatos, G. S., Gepstein, L., Hulot, J., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2414 · Cited by 59
Searching for better animal models of BPD: a perspective
Ambalavanan, N., & Morty, R. E. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00355.2016 · Cited by 57
Gene editing in mouse zygotes using the CRISPR/Cas9 system
Wefers, B., Bashir, S., Rossius, J., Wurst, W., & Kühn, R. (2017) · Methods · doi:10.1016/j.ymeth.2017.02.008 · Cited by 60
Next-Generation Sequencing of Genome-Wide CRISPR Screens
Yau, E. H., & Rana, T. M. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7514-3_13 · Cited by 57
Knockout of TRPC6 promotes insulin resistance and exacerbates glomerular injury in Akita mice
Wang, L., Chang, J., Buckley, A. F., & Spurney, R. F. (2019) · Kidney International · doi:10.1016/j.kint.2018.09.026 · Cited by 56
Cholesterol-rich lipid-mediated nanoparticles boost of transfection efficiency, utilized for gene editing by CRISPR-Cas9
Hosseini, E. S., Nikkhah, M., & Hosseinkhani, S. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s199104 · Cited by 57
ITR-Seq, a next-generation sequencing assay, identifies genome-wide DNA editing sites in vivo following adeno-associated viral vector-mediated genome editing
Breton, C. A., Clark, P., Wang, L., Greig, J. A., & Wilson, J. M. (2020) · BMC Genomics · doi:10.1186/s12864-020-6655-4 · Cited by 60
Molecular mechanisms, off‐target activities, and clinical potentials of genome editing systems
Zheng, N., Li, L., & Wang, X. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.34 · Cited by 59
CRISPR-based metabolic editing: Next-generation metabolic engineering in plants
Sabzehzari, M., Zeinali, M., & Naghavi, M. R. (2020) · Gene · doi:10.1016/j.gene.2020.144993 · Cited by 57
CRISPR/Cas9: Implications for Modeling and Therapy of Neurodegenerative Diseases
Yang, W., Tu, Z., Sun, Q., & Li, X. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00030 · Cited by 59
Heterogeneous gene duplications can be adaptive because they permanently associate overdominant alleles
Milesi, P., Weill, M., Lenormand, T., & Labbé, P. (2017) · Evolution Letters · doi:10.1002/evl3.17 · Cited by 56
Application of the gene editing tool, CRISPR-Cas9, for treating neurodegenerative diseases
Kolli, N., Lü, M., Maiti, P., Rossignol, J., & Dunbar, G. L. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.07.007 · Cited by 59
Advances on systems metabolic engineering of Bacillus subtilis as a chassis cell
Xiang, M., Kang, Q. K., & Zhang, D. (2020) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2020.07.005 · Cited by 58
Epigenetic editing: Dissecting chromatin function in context
Policarpi, C., Dabin, J., & Hackett, J. A. (2021) · BioEssays · doi:10.1002/bies.202000316 · Cited by 54
Virus-Host Interactions: From Unbiased Genetic Screens to Function
Ramage, H. R., & Cherry, S. R. (2015) · Annual Review of Virology · doi:10.1146/annurev-virology-100114-055238 · Cited by 55
CRISPR/Cas9: molecular tool for gene therapy to target genome and epigenome in the treatment of lung cancer
Sachdeva, M., Sachdeva, N., Pal, M., Gupta, N., Khan, I. A., Majumdar, M., & Tiwari, A. (2015) · Cancer Gene Therapy · doi:10.1038/cgt.2015.54 · Cited by 56
Rapid Screening for CRISPR-Directed Editing of the Drosophila Genome Using white Coconversion
Ge, D. T., Tipping, C., Brodsky, M. H., & Zamore, P. D. (2016) · G3 Genes Genomes Genetics · doi:10.1534/g3.116.032557 · Cited by 55
The gRNA-miRNA-gRNA Ternary Cassette Combining CRISPR/Cas9 with RNAi Approach Strongly Inhibits Hepatitis B Virus Replication
Wang, J., Chen, R., Zhang, R., Ding, S., Zhang, T., Yuan, Q., Guan, G., Chen, X., Zhang, T., Zhuang, H., et al. (2017) · Theranostics · doi:10.7150/thno.18114 · Cited by 56
Systematic analysis of human telomeric dysfunction using inducible telosome/shelterin CRISPR/Cas9 knockout cells
Kim, H., Li, F., He, Q., Deng, T., Xu, J. Q., Jin, F., Coarfa, C., Putluri, N., Liu, D., & Songyang, Z. (2017) · Cell Discovery · doi:10.1038/celldisc.2017.34 · Cited by 58
CRISPR/Cas9 genome editing: Fueling the revolution in cancer immunotherapy
Liu, X., & Zhao, Y. (2018) · Current Research in Translational Medicine · doi:10.1016/j.retram.2018.04.003 · Cited by 57

Authors: Sander, J. D., & Joung, J. K.
Affiliations: Harvard University (US)
Corresponding author: Joung, J Keith
ORCID: Sander, Jeffry D
Joung, J Keith
Venue: Nature Biotechnology
Publisher: Springer Science and Business Media LLC
Published: 2014-03-02
Volume: 32
Issue: 4
Pages: 347-355
ISSN: 0733-222X (ISSN-L)
1087-0156
1546-1696
DOI: 10.1038/nbt.2842
PMC: PMC4022601
OpenAlex: W2039705224
Cited by: 3,153
References: 102
Citations by year: 2026: 79 · 2025: 153 · 2024: 167 · 2023: 166 · 2022: 233 · 2021: 225 · 2020: 271 · 2019: 298 · 2018: 379 · 2017: 368 · 2016: 384 · 2015: 300 · 2014: 124
FWCI: 36.95
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature Biotechnology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of General Medical Sciences (DP1GM105378, R01GM088040)
National Center for Chronic Disease Prevention and Health Promotion (DP1 GM105378)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords: CRISPR/Cas9, genome editing, RNA-guided nucleases, engineered nucleases, gene expression regulation, targeted mutagenesis, molecular therapeutics
MeSH terms: Animals, Genetic Engineering, Humans, Rabbits, Genomics, Mice, Rats, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

CRISPR-Cas systems for editing, regulating and targeting genomes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks